Opaleye Management Inc.
Q1 2026 13F Holdings
- Locationboston, MA
- Num holdings
54
- Value ($000)
$759,221
- Date Filed 05/15/2026
- Form type13F-HR
- CIK 0001595855
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
HARROW INC | COM | 415858109 | $99.86M | 13 % | 2,832,230 | ||
LIQUIDIA CORPORATION | COM NEW | 53635D202 | $88.82M | 12 % | 2,545,000 | ||
ETON PHARMACEUTICALS INC | COM | 29772L108 | $70.58M | 9 % | 2,860,000 | ||
SOL-GEL TECHNOLOGIES LTD | SHS NEW | M8694L137 | $39.61M | 5 % | 500,000 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | $35.32M | 5 % | 123,000 | ||
APOGEE THERAPEUTICS INC | COM | 03770N101 | $32.83M | 4 % | 390,000 | ||
DISC MEDICINE INC | COM | 254604101 | $26.92M | 4 % | 421,000 | ||
UROGEN PHARMA LTD | COM | M96088105 | $25.71M | 3 % | 1,430,000 | ||
CRESCENT BIOPHARMA INC. | COM | G2545C104 | $24.11M | 3 % | 1,312,615 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | $22.79M | 3 % | 700,000 |
Rows Per Page
10
- 10
- 50
- 100